Cargando…

Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer

PURPOSE: Among cancer predisposition genes, most direct-to-consumer (DTC) genetic tests evaluate three Ashkenazi Jewish (AJ) founder mutations in BRCA1/2, which represent a small proportion of pathogenic or likely pathogenic variants (PLPV) in cancer predisposing genes. In this study, we investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desai, Neelam V., Barrows, Elizabeth D., Nielsen, Sarah M., Hatchell, Kathryn E., Anderson, Michael J., Haverfield, Eden V., Herrera, Blanca, Esplin, Edward D., Lucassen, Anneke, Tung, Nadine M., Isaacs, Claudine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2023
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581610/ https://www.ncbi.nlm.nih.gov/pubmed/37535880 http://dx.doi.org/10.1200/PO.22.00695

Ejemplares similares

The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives
por: Schmidlen, Tara J., et al.
Publicado: (2022)

Underdiagnosis of Hereditary Colorectal Cancers Among Medicare Patients: Genetic Testing Criteria for Lynch Syndrome Miss the Mark
por: Muller, Charles, et al.
Publicado: (2021)

Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis
por: Sturm, Amy C., et al.
Publicado: (2021)

Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer
por: Coughlin, Sarah E., et al.
Publicado: (2022)

Direct-to-consumer genetic testing
por: Horton, Rachel, et al.
Publicado: (2019)

Alerting relatives about heritable risks: the limits of confidentiality
por: Lucassen, Anneke, et al.
Publicado: (2018)

Ashkenazi Jewish and Other White APC I1307K Carriers Are at Higher Risk for Multiple Cancers
por: Forkosh, Esther, et al.
Publicado: (2022)

Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional Study
por: Ossa Gomez, Carlos Andrés, et al.
Publicado: (2022)

Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits
por: Nazareth, Shivani, et al.
Publicado: (2021)

Limitations and Pitfalls of Using Family Letters to Communicate Genetic Risk: a Qualitative Study with Patients and Healthcare Professionals
por: Dheensa, Sandi, et al.
Publicado: (2017)

Consumer Limitations on the Digitalization of the Insurance Market and Ways to Overcome Them
por: Bryzgalov, D. V., et al.
Publicado: (2022)

Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer
por: Esplin, Edward D., et al.
Publicado: (2022)

Nonspecific phenotype of Noonan syndrome diagnosed by whole exome sequencing
por: Coromilas, Alexandra, et al.
Publicado: (2015)

On Sexual Limitation in Hereditary Disease
por: Sedgwick, William
Publicado: (1861)

On Sexual Limitation in Hereditary Disease
por: Sedgwick, William
Publicado: (1861)

Clinical Genetic Testing for the Cardiomyopathies and Arrhythmias: A Systematic Framework for Establishing Clinical Validity and Addressing Genotypic and Phenotypic Heterogeneity
por: Garcia, John, et al.
Publicado: (2016)

Correction to: Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study
por: Haverfield, Eden V., et al.
Publicado: (2021)

Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study
por: Haverfield, Eden V., et al.
Publicado: (2021)

Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With Colorectal Cancer
por: Moretz, Chad, et al.
Publicado: (2022)

Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing
por: Chen, Elaine, et al.
Publicado: (2023)

CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer
por: Adib, Elio, et al.
Publicado: (2021)

P1686: VARIATION IN DIAGNOSTIC REQUESTS AND OUTCOMES FOR HEREDITARY THROMBOPHILIA -OVER TESTING AND UNDER TESTING
por: isaacs, S., et al.
Publicado: (2022)

The Challenges of Genome Analysis in the Health Care Setting
por: Lucassen, Anneke, et al.
Publicado: (2014)

Using a genetic test result in the care of family members: how does the duty of confidentiality apply?
por: Parker, Michael, et al.
Publicado: (2018)

Consent and Autonomy in the Genomics Era
por: Horton, Rachel, et al.
Publicado: (2019)

Genomic testing in healthcare: a hybrid space where clinical practice and research need to co-exist
por: Horton, Rachel, et al.
Publicado: (2019)

In the family: access to, and communication of, familial information in clinical practice
por: Lucassen, Anneke, et al.
Publicado: (2021)

Case Series of Autosomal Recessive Hereditary Spastic Paraplegia in Adults
por: Chakor, Rahul T., et al.
Publicado: (2021)

E-Commerce and Consumer Protection in India: The Emerging Trend
por: Chawla, Neelam, et al.
Publicado: (2021)

Using biomarkers in acute medicine to prevent hearing loss: should this require specific consent?
por: Coulson-Smith, Peta, et al.
Publicado: (2020)

Genetics of Hereditary Ataxia in Scottish Terriers
por: Urkasemsin, G., et al.
Publicado: (2017)

Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing
por: Dellefave-Castillo, Lisa M., et al.
Publicado: (2022)

Improving our model of cascade testing for hereditary cancer risk by leveraging patient peer support: a concept report
por: O’Neill, Suzanne C., et al.
Publicado: (2021)

A 10-year longitudinal evaluation of science policy interventions to promote sex and gender in health research
por: Haverfield, Jenna, et al.
Publicado: (2021)

‘Is this knowledge mine and nobody else's? I don't feel that.’ Patient views about consent, confidentiality and information-sharing in genetic medicine
por: Dheensa, Sandi, et al.
Publicado: (2016)

Approaching confidentiality at a familial level in genomic medicine: a focus group study with healthcare professionals
por: Dheensa, Sandi, et al.
Publicado: (2017)

Recent developments in genetic/genomic medicine
por: Horton, Rachel H., et al.
Publicado: (2019)

From Beyond the Grave: Use of Medical Information from the Deceased to Guide Care of Living Relatives
por: Tadros, Shereen, et al.
Publicado: (2020)

Re-imagining ‘the patient’: Linked lives and lessons from genomic medicine
por: Weller, Susie, et al.
Publicado: (2022)

Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
por: Digennaro, M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_amlvuioontr2pno02h06s36rch